This study was funded by ZonMw, a Dutch organization for Health Research and Development, project number 80-82310-97-12066.

Medical treatment for early fetal death (less than 24 weeks) (Review)

12 June 2012.

In women with an incomplete evacuation of the uterus after misoprostol treatment, expectant management is an effective and safe option. This finding could restrain the use of curettage in women that have used misoprostol in the treatment of first trimester miscarriage.

Curettage is not cost-effective compared with expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment. This indicates that curettage in this group should be restrained.